These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

529 related items for PubMed ID: 12370407

  • 1. Allograft rejection by primed/memory CD8+ T cells is CD154 blockade resistant: therapeutic implications for sensitized transplant recipients.
    Zhai Y, Meng L, Gao F, Busuttil RW, Kupiec-Weglinski JW.
    J Immunol; 2002 Oct 15; 169(8):4667-73. PubMed ID: 12370407
    [Abstract] [Full Text] [Related]

  • 2. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
    Zhai Y, Meng L, Busuttil RW, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 2003 Mar 15; 170(6):3024-8. PubMed ID: 12626556
    [Abstract] [Full Text] [Related]

  • 3. Critical role of CD4 help in CD154 blockade-resistant memory CD8 T cell activation and allograft rejection in sensitized recipients.
    Wu Z, Wang Y, Gao F, Shen X, Zhai Y, Kupiec-Weglinski JW.
    J Immunol; 2008 Jul 15; 181(2):1096-102. PubMed ID: 18606661
    [Abstract] [Full Text] [Related]

  • 4. Alloreactive CD8 T-cell primed/memory responses and accelerated graft rejection in B-cell-deficient sensitized mice.
    Ji H, Shen XD, Gao F, Busuttil RW, Zhai Y, Kupiec-Weglinski JW.
    Transplantation; 2011 May 27; 91(10):1075-81. PubMed ID: 21427633
    [Abstract] [Full Text] [Related]

  • 5. Treatment of allograft recipients with donor-specific transfusion and anti-CD154 antibody leads to deletion of alloreactive CD8+ T cells and prolonged graft survival in a CTLA4-dependent manner.
    Iwakoshi NN, Mordes JP, Markees TG, Phillips NE, Rossini AA, Greiner DL.
    J Immunol; 2000 Jan 01; 164(1):512-21. PubMed ID: 10605049
    [Abstract] [Full Text] [Related]

  • 6. Two-signal blockade with anti-CD45RB and anti-CD154 monoclonal antibodies inhibits graft rejection via CD4-dependent mechanisms in allogeneic skin transplantation.
    Kim EY, Lee EN, Lee J, Park HJ, Chang CY, Jung DY, Choi SY, Lee SK, Joh JW, Kim SJ.
    Exp Mol Med; 2006 Jun 30; 38(3):284-94. PubMed ID: 16819287
    [Abstract] [Full Text] [Related]

  • 7. The role of the IL-2 pathway in costimulation blockade-resistant rejection of allografts.
    Jones TR, Ha J, Williams MA, Adams AB, Durham MM, Rees PA, Cowan SR, Pearson TC, Larsen CP.
    J Immunol; 2002 Feb 01; 168(3):1123-30. PubMed ID: 11801646
    [Abstract] [Full Text] [Related]

  • 8. Memory alloreactive B cells and alloantibodies prevent anti-CD154-mediated allograft acceptance.
    Burns AM, Ma L, Li Y, Yin D, Shen J, Xu J, Chong AS.
    J Immunol; 2009 Feb 01; 182(3):1314-24. PubMed ID: 19155477
    [Abstract] [Full Text] [Related]

  • 9. CD154 blockade alters innate immune cell recruitment and programs alloreactive CD8+ T cells into KLRG-1(high) short-lived effector T cells.
    Ferrer IR, Wagener ME, Song M, Ford ML.
    PLoS One; 2012 Feb 01; 7(7):e40559. PubMed ID: 22792369
    [Abstract] [Full Text] [Related]

  • 10. Skin allograft maintenance in a new synchimeric model system of tolerance.
    Iwakoshi NN, Markees TG, Turgeon N, Thornley T, Cuthbert A, Leif J, Phillips NE, Mordes JP, Greiner DL, Rossini AA.
    J Immunol; 2001 Dec 01; 167(11):6623-30. PubMed ID: 11714833
    [Abstract] [Full Text] [Related]

  • 11. TLR agonists abrogate costimulation blockade-induced prolongation of skin allografts.
    Thornley TB, Brehm MA, Markees TG, Shultz LD, Mordes JP, Welsh RM, Rossini AA, Greiner DL.
    J Immunol; 2006 Feb 01; 176(3):1561-70. PubMed ID: 16424185
    [Abstract] [Full Text] [Related]

  • 12. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K, Schönbeck U, Mach F, Libby P, Mitchell RN.
    J Immunol; 2000 Sep 15; 165(6):3506-18. PubMed ID: 10975872
    [Abstract] [Full Text] [Related]

  • 13. Critical role of OX40 in CD28 and CD154-independent rejection.
    Demirci G, Amanullah F, Kewalaramani R, Yagita H, Strom TB, Sayegh MH, Li XC.
    J Immunol; 2004 Feb 01; 172(3):1691-8. PubMed ID: 14734751
    [Abstract] [Full Text] [Related]

  • 14. Monoclonal antibody treatment to prolong the secondary cardiac allograft survival in alloantigen-primed mice.
    Xie B, Chen J, Wang F, Lan T, Wang Y, Xia J, Li Z, Xie Q, Huang R, Qi Z.
    Scand J Immunol; 2010 May 01; 71(5):345-52. PubMed ID: 20500685
    [Abstract] [Full Text] [Related]

  • 15. CD44/CD70 blockade and anti-CD154/LFA-1 treatment synergistically suppress accelerated rejection and prolong cardiac allograft survival in mice.
    Shao W, Yan G, Lin Y, Chen J, Dai H, Wang F, Xi Y, Thorlacius H, Qi Z.
    Scand J Immunol; 2011 Nov 01; 74(5):430-7. PubMed ID: 21707692
    [Abstract] [Full Text] [Related]

  • 16. Critical, but conditional, role of OX40 in memory T cell-mediated rejection.
    Vu MD, Clarkson MR, Yagita H, Turka LA, Sayegh MH, Li XC.
    J Immunol; 2006 Feb 01; 176(3):1394-401. PubMed ID: 16424166
    [Abstract] [Full Text] [Related]

  • 17. The CD154-CD40 T cell costimulation pathway is required for host sensitization of CD8(+) T cells by skin grafts via direct antigen presentation.
    Zhai Y, Shen XD, Gao F, Coito AJ, Wasowska BA, Salama A, Schmitt I, Busuttil RW, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 2002 Aug 01; 169(3):1270-6. PubMed ID: 12133948
    [Abstract] [Full Text] [Related]

  • 18. IFN-gamma dictates allograft fate via opposing effects on the graft and on recipient CD8 T cell responses.
    Coley SM, Ford ML, Hanna SC, Wagener ME, Kirk AD, Larsen CP.
    J Immunol; 2009 Jan 01; 182(1):225-33. PubMed ID: 19109153
    [Abstract] [Full Text] [Related]

  • 19. Cutting edge: CD4+CD25+ alloantigen-specific immunoregulatory cells that can prevent CD8+ T cell-mediated graft rejection: implications for anti-CD154 immunotherapy.
    van Maurik Av, Herber M, Wood KJ, Jones ND.
    J Immunol; 2002 Nov 15; 169(10):5401-4. PubMed ID: 12421913
    [Abstract] [Full Text] [Related]

  • 20. Islet allograft rejection in nonobese diabetic mice involves the common gamma-chain and CD28/CD154-dependent and -independent mechanisms.
    Demirci G, Strom TB, Li XC.
    J Immunol; 2003 Oct 01; 171(7):3878-85. PubMed ID: 14500690
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.